Anti-retroviral drugs: current state and development in the next decade
Acta Pharmaceutica Sinica B
;
(6): 131-136, 2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-690925
ABSTRACT
The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV drugs remain in phase III clinical trials. This review summarizes current information on ARV drugs in phase III clinical trials and focuses on the development of ARV drugs in the next decade.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Inglés
Revista:
Acta Pharmaceutica Sinica B
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS